FI57401C - Foerfarande foer framstaellning av 1-alkyl-4-fenyl- eller -4-(2'-tienyl)-2(1h)-kinazolinoner - Google Patents
Foerfarande foer framstaellning av 1-alkyl-4-fenyl- eller -4-(2'-tienyl)-2(1h)-kinazolinoner Download PDFInfo
- Publication number
- FI57401C FI57401C FI1870/72A FI187072A FI57401C FI 57401 C FI57401 C FI 57401C FI 1870/72 A FI1870/72 A FI 1870/72A FI 187072 A FI187072 A FI 187072A FI 57401 C FI57401 C FI 57401C
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- formula
- phenyl
- thienyl
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 39
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- -1 alkaline earth metal salt Chemical class 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 7
- 229910052727 yttrium Inorganic materials 0.000 claims description 7
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 5
- 239000012024 dehydrating agents Substances 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- RYXPMWYHEBGTRV-UHFFFAOYSA-N Omeprazole sodium Chemical compound [Na+].N=1C2=CC(OC)=CC=C2[N-]C=1S(=O)CC1=NC=C(C)C(OC)=C1C RYXPMWYHEBGTRV-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 12
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 6
- 239000002808 molecular sieve Substances 0.000 description 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 238000006356 dehydrogenation reaction Methods 0.000 description 5
- QUSNBJAOOMFDIB-UHFFFAOYSA-N monoethyl amine Natural products CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229940043279 diisopropylamine Drugs 0.000 description 4
- XZRLSZCBYSWKMI-UHFFFAOYSA-N n-propan-2-ylcyclohexanimine Chemical compound CC(C)N=C1CCCCC1 XZRLSZCBYSWKMI-UHFFFAOYSA-N 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 4
- VRSOLQVXJWPDHD-UHFFFAOYSA-N 3-methyl-n-propan-2-ylcyclohexan-1-imine Chemical compound CC(C)N=C1CCCC(C)C1 VRSOLQVXJWPDHD-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 229910003002 lithium salt Inorganic materials 0.000 description 3
- 159000000002 lithium salts Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 125000005270 trialkylamine group Chemical group 0.000 description 2
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- ZUYKJZQOPXDNOK-UHFFFAOYSA-N 2-(ethylamino)-2-thiophen-2-ylcyclohexan-1-one;hydrochloride Chemical class Cl.C=1C=CSC=1C1(NCC)CCCCC1=O ZUYKJZQOPXDNOK-UHFFFAOYSA-N 0.000 description 1
- ZMMGDQQBYJCGGW-UHFFFAOYSA-N 6-methyl-1-propan-2-yl-5,6,7,8-tetrahydroquinazolin-2-one Chemical compound CC1CC=2C=NC(N(C=2CC1)C(C)C)=O ZMMGDQQBYJCGGW-UHFFFAOYSA-N 0.000 description 1
- RRWXXCGCGFAXAF-UHFFFAOYSA-N 6-methyl-4-phenyl-1-propan-2-yl-5,6,7,8-tetrahydroquinazolin-2-one Chemical compound N=1C(=O)N(C(C)C)C=2CCC(C)CC=2C=1C1=CC=CC=C1 RRWXXCGCGFAXAF-UHFFFAOYSA-N 0.000 description 1
- YKFXBRUJMZNBAN-UHFFFAOYSA-N 7-methyl-4-phenyl-1-propan-2-yl-5,6,7,8-tetrahydroquinazolin-2-one Chemical compound N=1C(=O)N(C(C)C)C=2CC(C)CCC=2C=1C1=CC=CC=C1 YKFXBRUJMZNBAN-UHFFFAOYSA-N 0.000 description 1
- XSSGLBGLRFZFQV-UHFFFAOYSA-N C(C)(C)C1(CC=CC=C1)N1C(N=CC2=CC=C(C=C12)C)=O Chemical compound C(C)(C)C1(CC=CC=C1)N1C(N=CC2=CC=C(C=C12)C)=O XSSGLBGLRFZFQV-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- JPQASKLLWAWQMT-UHFFFAOYSA-N O=CC1Nc2ccccc2C=N1 Chemical compound O=CC1Nc2ccccc2C=N1 JPQASKLLWAWQMT-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- FNIATMYXUPOJRW-UHFFFAOYSA-N cyclohexylidene Chemical group [C]1CCCCC1 FNIATMYXUPOJRW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- NLDYACGHTUPAQU-UHFFFAOYSA-N tetracyanoethylene Chemical group N#CC(C#N)=C(C#N)C#N NLDYACGHTUPAQU-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 1
- FUCBQMFTYFQCOB-UHFFFAOYSA-N trityl perchlorate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OCl(=O)(=O)=O)C1=CC=CC=C1 FUCBQMFTYFQCOB-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000004018 waxing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16096071A | 1971-07-08 | 1971-07-08 | |
| US16096071 | 1971-07-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI57401B FI57401B (fi) | 1980-04-30 |
| FI57401C true FI57401C (fi) | 1980-08-11 |
Family
ID=22579209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI1870/72A FI57401C (fi) | 1971-07-08 | 1972-06-30 | Foerfarande foer framstaellning av 1-alkyl-4-fenyl- eller -4-(2'-tienyl)-2(1h)-kinazolinoner |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4066665A (en, 2012) |
| JP (4) | JPS577150B1 (en, 2012) |
| AT (1) | AT338270B (en, 2012) |
| BE (1) | BE785937A (en, 2012) |
| BG (1) | BG19170A3 (en, 2012) |
| CA (1) | CA1002953A (en, 2012) |
| CH (2) | CH602668A5 (en, 2012) |
| CS (1) | CS189583B2 (en, 2012) |
| DD (3) | DD106171A5 (en, 2012) |
| DE (3) | DE2254326A1 (en, 2012) |
| ES (1) | ES404598A1 (en, 2012) |
| FI (1) | FI57401C (en, 2012) |
| FR (2) | FR2144753B1 (en, 2012) |
| GB (1) | GB1383255A (en, 2012) |
| IE (1) | IE36541B1 (en, 2012) |
| IL (1) | IL39845A (en, 2012) |
| NL (1) | NL7209322A (en, 2012) |
| NO (1) | NO136838C (en, 2012) |
| OA (1) | OA04129A (en, 2012) |
| PH (1) | PH13454A (en, 2012) |
| PL (1) | PL89011B1 (en, 2012) |
| RO (1) | RO63336A (en, 2012) |
| SE (1) | SE406196B (en, 2012) |
| SU (1) | SU528032A3 (en, 2012) |
| YU (1) | YU177672A (en, 2012) |
| ZA (1) | ZA724688B (en, 2012) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996227A (en) * | 1971-07-08 | 1976-12-07 | Sandoz, Inc. | 7-Methyl-1-isopropyl-4-phenyl-5,6,7,8-tetrahydro-2(1H)-quinazolinone |
| JPS5271483A (en) | 1975-12-11 | 1977-06-14 | Sumitomo Chem Co Ltd | Synthesis of 2(1h)-quinazolinone derivatives |
| CH642638A5 (de) * | 1977-09-06 | 1984-04-30 | Sandoz Ag | Verfahren zur herstellung von chinazolin-2(1h)-onen. |
| JPS5661198A (en) * | 1979-10-24 | 1981-05-26 | Shinto Paint Co Ltd | Method of painting board for wiring conductive print |
| JPS5878495A (ja) * | 1981-11-05 | 1983-05-12 | セイコーエプソン株式会社 | プリント配線板の製造方法 |
| JPS5878494A (ja) * | 1981-11-05 | 1983-05-12 | セイコーエプソン株式会社 | プリント配線板の製造方法 |
| JPS58222593A (ja) * | 1982-02-24 | 1983-12-24 | 日立化成工業株式会社 | 金属芯入りプリント配線板用基板の製造法 |
| US4601916A (en) * | 1984-07-18 | 1986-07-22 | Kollmorgen Technologies Corporation | Process for bonding metals to electrophoretically deposited resin coatings |
| JPS6133463U (ja) * | 1984-07-30 | 1986-02-28 | 三菱電線工業株式会社 | 金属ベ−ス基板 |
| JPS61156000U (en, 2012) * | 1985-03-19 | 1986-09-27 | ||
| US6951707B2 (en) * | 2001-03-08 | 2005-10-04 | Ppg Industries Ohio, Inc. | Process for creating vias for circuit assemblies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3553199A (en) * | 1967-03-17 | 1971-01-05 | Hoffmann La Roche | Reaction of 2-aminobenzophenone amines and benzhydryl amines with di-leaveing group-substituted ethane |
| US3723432A (en) * | 1968-11-12 | 1973-03-27 | Sandoz Ag | 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation |
| US3549635A (en) * | 1968-07-01 | 1970-12-22 | Sandoz Ag | Preparation of substituted-2(1h)-quinazolinones |
| US3563990A (en) * | 1969-03-18 | 1971-02-16 | Sandoz Ag | 1-substituted-4-aryl-2(1h)-quinazolinones |
| DD202218A5 (de) * | 1982-04-27 | 1983-08-31 | Orion Radio | Verfahren und schaltungsanordnung zur erzeugung einer phasengetasteten kohaerenten traegerfrequenz |
-
0
- BE BE785937D patent/BE785937A/xx unknown
-
1972
- 1972-06-28 CH CH967772A patent/CH602668A5/xx not_active IP Right Cessation
- 1972-06-28 CH CH1000775A patent/CH587804A5/xx not_active IP Right Cessation
- 1972-06-29 SE SE7208555A patent/SE406196B/xx unknown
- 1972-06-30 FI FI1870/72A patent/FI57401C/fi active
- 1972-06-30 PH PH13677A patent/PH13454A/en unknown
- 1972-06-30 NO NO2357/72A patent/NO136838C/no unknown
- 1972-07-03 NL NL7209322A patent/NL7209322A/xx not_active Application Discontinuation
- 1972-07-04 FR FR7224092A patent/FR2144753B1/fr not_active Expired
- 1972-07-04 GB GB3116172A patent/GB1383255A/en not_active Expired
- 1972-07-04 CS CS724738A patent/CS189583B2/cs unknown
- 1972-07-05 DE DE2254326*A patent/DE2254326A1/de not_active Withdrawn
- 1972-07-05 DE DE2254325*A patent/DE2254325A1/de not_active Withdrawn
- 1972-07-05 DE DE2232919A patent/DE2232919A1/de not_active Withdrawn
- 1972-07-06 RO RO7200071526A patent/RO63336A/ro unknown
- 1972-07-06 YU YU01776/72A patent/YU177672A/xx unknown
- 1972-07-06 IL IL39845A patent/IL39845A/xx unknown
- 1972-07-06 IE IE961/72A patent/IE36541B1/xx unknown
- 1972-07-06 ES ES404598A patent/ES404598A1/es not_active Expired
- 1972-07-06 OA OA54634A patent/OA04129A/xx unknown
- 1972-07-06 PL PL1972156542A patent/PL89011B1/pl unknown
- 1972-07-06 BG BG020905A patent/BG19170A3/xx unknown
- 1972-07-06 SU SU1808956A patent/SU528032A3/ru active
- 1972-07-07 DD DD170839*A patent/DD106171A5/xx unknown
- 1972-07-07 DD DD164258A patent/DD101400A5/xx unknown
- 1972-07-07 JP JP6762772A patent/JPS577150B1/ja active Pending
- 1972-07-07 AT AT582972A patent/AT338270B/de not_active IP Right Cessation
- 1972-07-07 CA CA146,572A patent/CA1002953A/en not_active Expired
- 1972-07-07 DD DD170837*A patent/DD106175A5/xx unknown
- 1972-07-07 ZA ZA724688A patent/ZA724688B/xx unknown
-
1974
- 1974-02-07 FR FR7404125A patent/FR2208681B1/fr not_active Expired
- 1974-06-19 US US05/480,626 patent/US4066665A/en not_active Expired - Lifetime
-
1980
- 1980-06-26 JP JP55086000A patent/JPS585198B2/ja not_active Expired
- 1980-06-26 JP JP55085999A patent/JPS58422B2/ja not_active Expired
- 1980-06-26 JP JP8599880A patent/JPS56115758A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI57401C (fi) | Foerfarande foer framstaellning av 1-alkyl-4-fenyl- eller -4-(2'-tienyl)-2(1h)-kinazolinoner | |
| CN102603660B (zh) | 一种1h-1,2,3-三唑类化合物的制备方法 | |
| Wang et al. | L-Pipecolinic acid derived Lewis base organocatalyst for asymmetric reduction of N-aryl imines by trichlorosilane: Effects of the side amide group on catalytic performances | |
| FI64372B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 1-substitueradaminometyl-1-etyl-indolo-(2,3-a)-kinolizidiner | |
| Katritzky et al. | The chemistry of benzotriazole. A novel method for the synthesis of symmetrical vicinal tertiary and secondary diamines | |
| Dajek et al. | trans-1, 2-Diaminocyclohexane-based sulfonamides as effective hydrogen-bonding organocatalysts for asymmetric Michael–hemiacetalization reaction | |
| Che et al. | A simple synthetic route to N, N′-dialkyl-2, 11-diaza [3.3](2, 6)-pyridinophanes. Crystal structures of N, N′-di-tert-butyl-2, 11-diaza [3.3](2, 6) pyridinophane and its copper (II) complex | |
| JP2005516036A (ja) | 非ラセミｓｙｎ−１−（４−ヒドロキシ−フェニル）−２−（４−ヒドロキシ−４−フェニル−ピペリジン−１−イル）−１−プロパノ−ル化合物の製造方法 | |
| McGarraugh et al. | Novel bifunctional sulfonamides catalyze an enantioselective conjugate addition | |
| SU519124A3 (ru) | Способ получени трициклических иминов | |
| Tikhonova et al. | Sulfur-mediated synthesis of unsymmetrically substituted N-aryl oxalamides by the cascade thioamidation/cyclocondensation and hydrolysis reaction | |
| CN102690227A (zh) | 一种光学活性四氢吡啶衍生物及其制备方法 | |
| JPH0641105A (ja) | グリシド誘導体の製造方法 | |
| CN103554023B (zh) | 吖啶衍生物的合成方法及合成的多环吖啶衍生物 | |
| CN110372564A (zh) | 一种2-氨基-4-酰基吡咯化合物及其制备方法 | |
| Kobelev et al. | Planar-Chiral Macrobicycles Comprising Cyclam Moiety | |
| CN100537582C (zh) | 一种双二茂铁膦二亚胺结构及其合成方法 | |
| WO2021002407A1 (ja) | フルオロアルキル基含有化合物とその製造方法 | |
| Wu et al. | A New Class of Chiral Pincer-Type PNN Ligands for Pd-Catalyzed Asymmetric Allylic Alkylation | |
| KR101815001B1 (ko) | 고 입체순도를 갖는 4-치환된-5-원고리-설파미데이트-5-포스포네이트 화합물 및 이의 제조방법 | |
| CN115043810B (zh) | 一种非金属催化的不对称碳氢键氧化制备手性碳氢键氧化产物的方法 | |
| IL29640A (en) | Process for the manufacture of benzodiazepine derivatives | |
| KR101345749B1 (ko) | 고 입체순도를 갖는 4,5-다이아릴 5-원고리 설파미데이트의 제조방법 | |
| Gueremy et al. | 4-Amino-6-chloro-2-piperazinopyrimidines with selective affinity for. alpha. 2-adrenoceptors | |
| SG189465A1 (en) | Novel phase transfer catalysts |